
Strate Labs — a research-compound vendor that operated for roughly a decade — began winding down on July 1, 2026, replacing its storefront with a closure notice and clearance discounts across the catalog. For buyers who used it as a default source for peptides, SARMs, and blends, the question is immediate: where do you go now?
We've tracked peptide vendors across pricing, COA testing, catalog depth, and shipping reliability for months. Here are the alternatives worth considering — and what to watch out for during the transition.
Update 2026-11-17
The storefront is now fully dark, and the closure notice has gained both a stated reason and two referral vendors. Checked today, stratelabs.com serves a single page headed "Closure Notice" with no catalog, no clearance pricing and no sign-in. It reads: "StrateLabs has permanently closed... The regulatory landscape around our industry has shifted in ways that make it impossible for us to continue operating in the way you've come to expect from us — with the quality, transparency, and integrity that we've always insisted on. Rather than compromise on any of that, we're choosing to close our doors." The July wind-down notice this article was written against gave no reason at all. We could not establish when the page changed: the Wayback Machine holds one capture of the domain since September (October 17, 2026) and none after it.
The notice also refers departing customers to two named vendors — Chemistry Works (chemistry.works) and GL Peptides (glpeptides.is) — under the heading "Trusted Vendors," with a disclaimer that "Chemistry Works and GL Peptides are independent companies and are not affiliated with StrateLabs" and that the referrals are "solely to help customers find continued service following our closure."
What we verified ourselves on November 17, 2026:
- All three domains share one Cloudflare account.
stratelabs.com,chemistry.worksandglpeptides.isresolve on the same assigned Cloudflare nameserver pair (rommy.ns.cloudflare.comandraphaela.ns.cloudflare.com). Cloudflare hands each account a pseudo-random pair out of hundreds, so three domains landing on one pair points to a single account holding the DNS for all three. That establishes common DNS control, not common ownership — one contractor managing all three zones would look identical — but it means "independent companies and not affiliated" is unverified rather than established, and the notice does not disclose the overlap. - Neither referral is a post-closure domain.
chemistry.workswas registered on August 1, 2022 andglpeptides.ison July 9, 2025, both before the July 2026 wind-down. So neither matches the newly-registered-lookalike pattern described further down this article. - Both serve live storefronts with public lab-results pages. Chemistry Works lists research peptides and supplies; GL Peptides lists vials plus pre-filled pens and cites Janoshik testing.
We do not track, price-monitor or COA-verify either referral vendor. Neither appears in our rankings or has price history in our data, so this is not a recommendation for or against them — it is the context the referral page does not give.
One practical change: with the catalog gone, the "place a final clearance order to use a balance" option described below no longer exists. Chargeback and documentation are the remaining routes for a pending order or an unused balance. Everything else in this article — the legal timeline, the vendor comparison, and the vetting criteria — still stands.
Why Did Strate Labs Shut Down?
Strate Labs sold a broad mix of formats — peptides, oral capsules, topical blends, and SARMs — with batch-coded Certificates of Analysis and tamper-evident packaging. It was an established name, not a fly-by-night operation. The company gave no reason in its July wind-down notice; the closure notice now on the domain cites a shift in "the regulatory landscape" without naming a specific action (see the update above). The legal timeline is hard to ignore:
1. Eli Lilly litigation over tirzepatide. Strate Labs was a named respondent in Eli Lilly's action targeting grey-market tirzepatide imports, filed in March 2024. Carrying patented GLP-1 compounds put the company directly in the crosshairs of pharmaceutical enforcement.
2. A default judgment. Strate Labs was found in default in the matter in May 2024 — a legal position that leaves a company exposed to the full weight of the claims against it.
3. An ITC cease-and-desist order. In early 2025 the U.S. International Trade Commission issued a cease-and-desist order tied to the case, restricting the import and sale of the compounds at issue.
That sequence — lawsuit, default, cease-and-desist — is the same pattern of pressure that has closed other grey-market GLP-1 sellers over the past 18 months. A July 2026 wind-down with clearance pricing is what the end of that road tends to look like.
For the bigger context on the wave of closures, see our running timeline: Every Peptide Vendor That Shut Down (2025-2026).
Is There a Real Strate Labs Rebrand?
No verified rebrand has been announced. When a vendor closes under a default judgment and an ITC order, relaunching under a near-identical name recreates the exact liability the principals just walked away from — a poor legal strategy that re-establishes intent and continuity for any future action.
Expect opportunistic impersonator sites to appear trading on the Strate Labs name. Treat any "Strate Labs is back" domain with heavy skepticism: check the registration date with a whois lookup (domains registered in mid-2026 with privacy-shielded registrants are a textbook red flag), and don't transact with an unverified successor. Use the tracked alternatives below instead.
What to Look for in an Alternative Vendor
Not every vendor that surfaces after a major closure deserves your trust. Some appear specifically to capture displaced customers. What actually matters:
Third-party COA testing — A Certificate of Analysis from an independent lab confirms purity and identity. Vendors that publish COAs for every batch are investing in verification. Those that don't are asking you to trust their word.
Established track record — Vendors operating 12+ months with consistent quality and shipping are safer than brand-new operations that appeared after the shutdown.
Transparent pricing — Clear per-vial prices with dosage amounts and concentrations listed. No hidden fees, no bait-and-switch on strength.
Catalog depth — Vendors carrying a broad catalog signal operational maturity. A five-product catalog suggests a dropshipper, not a supplier.
4 Best Strate Labs Alternatives
The ranked list below is live from our vendor database — it reorders itself when our scoring changes, so it is the current order rather than a snapshot. The write-ups that follow explain why each vendor is on it.
LDAminos
9.9/1040% OFF · code thepeptidecatalogPartner vendor with verified inventory and COA documentation.
Nura Peptide
10.0/1030% OFF · code thepeptidecatalogNiche-format vendor — oral capsule peptides, pre-mixed nasal solutions, and a rare Reta + Cagrilintide combo blend, all 30% off with code thepeptidecatalog.
Ascension Peptides
9.5/1050% OFF · code THEPEPTIDECATALOGLowest effective pricing in the market after an exclusive 50% off through our link. Independent COA testing across the catalog.
Ion Peptide
9.2/1015% OFF · code thepeptidecatalogStrong blend lineup and competitive singles pricing. Pre-mixed combinations simplify reconstitution and dosing.
Mile High Compounds
8.5/1010% OFF · code thepeptidecatalogPartner vendor with verified inventory and COA documentation.
EZ Peptides
9.6/1010% OFF · code thepeptidecatalogBroadest verified catalog with QR-linked COAs on every product. Fast domestic shipping and a 30-day guarantee.
Swiss Chems
9.2/1010% OFF · code THEPEPTIDECATALOGBroad catalog with international shipping — useful for researchers outside the US.
We rank vendors using a weighted system: price (40%), COA verification (30%), and reputation (30%), with a floor score of 8.0. Every vendor below has operated for 12+ months and is monitored continuously.
The Peptide Catalog earns a commission when you buy through the vendor links on this page, at no extra cost to you. Commission rates differ between vendors; the ranking above follows the scoring method just described, not the rate we are paid.
The compounds discussed below — including retatrutide — are sold by these vendors as research chemicals not for human consumption. Retatrutide in particular remains an investigational compound with no FDA-approved indication.

